Very early researchStudy completedNCT04936997What this trial is testingImmune Response to the COVID-19 VaccineWho this might be right forCovid19CancerMalignancy+1 more University of Arizona 20
Testing effectiveness (Phase 2)Ended earlyNCT02010203What this trial is testingHS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBTWho this might be right forBladder Cancer Heat Biologics 104
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06047015What this trial is testingIrreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal CancerWho this might be right forLiver Metastasis Colon Cancer University of Saskatchewan 12
Not applicableEnded earlyNCT03701438What this trial is testingImmune Response to Influenza Vaccine in Adults With B-cell Malignancies Treated With IdelalisibWho this might be right forB-cell Malignancies Gilead Sciences 2
Early research (Phase 1)UnknownNCT02169388What this trial is testingIntestinal Microflora in Colorectal Cancer (CRC) After ChemotherapyWho this might be right forGastrointestinal NeoplasmsColorectal CancerEffects of Chemotherapy+2 more Shandong University 30
Not applicableStudy completedNCT00481637What this trial is testingStudy to Evaluate Immune Responses in Neurologically Normal Cancer PatientsWho this might be right forCancer Rockefeller University 33
Not applicableNot Yet RecruitingNCT04707365What this trial is testingMicroenvironment and Immunity of Digestive Cancers - East Paris Multicentric CohortWho this might be right forColorectal CancerPancreas TumorBiliary Tract Tumor+1 more Assistance Publique - Hôpitaux de Paris 200
Not applicableUnknownNCT04878822What this trial is testingImmunogenicity of Covid-19 Vaccination for Patients With Hematological MalignanciesWho this might be right forImmunogenicityHematological MalignanciesCovid-19+1 more Ospedale di Circolo - Fondazione Macchi 300
Not applicableLooking for participantsNCT07422337What this trial is testingA Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received BlinatumomabWho this might be right forB-Cell ALLB-Cell Acute Lymphoblastic LeukaemiaB-Cell Lymphoblastic Leukemia+5 more Arkansas Children's Hospital Research Institute 300
Not applicableWithdrawnNCT01274572What this trial is testingBlood for Immune Response to Provenge® in HRPCWho this might be right forProstate Cancer Mary Crowley Medical Research Center
Early research (Phase 1)Ended earlyNCT00585845What this trial is testingStudy of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard TreatmentWho this might be right forMalignant Epithelial MesotheliomaAdenocarcinoma of the PancreasCarcinoma, Non-Small-Cell Lung+1 more Anza Therapeutics, Inc. 17
Not applicableLooking for participantsNCT05736029What this trial is testingPredicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using MultiomicsWho this might be right forNon Small Cell Lung CancerHealthy OncoHost Ltd. 350
Post-approval studies (Phase 4)Active Not RecruitingNCT03520660What this trial is testingPeople With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral AgentsWho this might be right forDiabetes MellitusHepatitis C, ChronicCardiovascular Diseases National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 121
Testing effectiveness (Phase 2)Looking for participantsNCT06339424What this trial is testingAtezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Chang Gung Memorial Hospital 45
Large-scale testing (Phase 3)Study completedNCT00345878What this trial is testingStudy to Evaluate the Immune Response and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 YearsWho this might be right forInfections, Papillomavirus GlaxoSmithKline 271
Testing effectiveness (Phase 2)Ended earlyNCT00006478What this trial is testingVaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Nebraska 19
Testing effectiveness (Phase 2)UnknownNCT04602013What this trial is testingSintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell CarcinomaWho this might be right forLocally Advanced Esophageal Squamous Cell Carcinoma Sichuan Cancer Hospital and Research Institute 53
Early research (Phase 1)Study completedNCT01675765What this trial is testingSafety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Aduro Biotech, Inc. 60
Very early researchActive Not RecruitingNCT06959563What this trial is testingEarly Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPVWho this might be right forHPV Infection Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair 20
Not applicableStudy completedNCT00086242What this trial is testingTelephone Counseling or Standard Care in Patients Who Have Completed Treatment for Stages I, II, or III Cervical CancerWho this might be right forCervical CancerPsychosocial Effects of Cancer and Its Treatment University of California, Irvine 36